TG and thyroid cancer: The carcinogenicity of BRAFV600E in the thyroid glands was first demonstrated in vivo in Tg-BrafV600E transgenic mice expressing BRAFV600E under control of thyroid-specific thyroglobulin (Tg) promoter; these mice developed thyroid cancers very early in life [2].